2326 - 2350 of 9039 Results
Title
Year
- Expectations of Benefit in a Trial of a Candidate Disease‐Modifying Treatment for Parkinson Disease2021RESTRICTEDTitle: Expectations of Benefit in a Trial of a Candidate Disease‐Modifying Treatment for Parkinson DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1964End Page: 1967Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28630Citation Count: 6
- Detecting Sensitive Mobility Features for Parkinson's Disease Stages Via Machine Learning2021RESTRICTEDTitle: Detecting Sensitive Mobility Features for Parkinson's Disease Stages Via Machine LearningJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 9Start Page: 2144End Page: 2155Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28631Citation Count: 89
- Comparing the Two Prodromal Parkinson's Disease Research Criteria—Lessons for Future Studies2021RESTRICTEDTitle: Comparing the Two Prodromal Parkinson's Disease Research Criteria—Lessons for Future StudiesJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 7Start Page: 1731End Page: 1732Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28637Citation Count: 8
- Reply to: “Increased alpha‐Synuclein Level in CD45+ Blood Cells in Asymptomatic Carriers of GBA Mutations”2021RESTRICTEDTitle: Reply to: “Increased alpha‐Synuclein Level in CD45+ Blood Cells in Asymptomatic Carriers of GBA Mutations”Journal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1998End Page: 1999Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28678Citation Count: 0
- α‐Synuclein in Plasma‐Derived Extracellular Vesicles Is a Potential Biomarker of Parkinson's Disease2021OPENTitle: α‐Synuclein in Plasma‐Derived Extracellular Vesicles Is a Potential Biomarker of Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 11Start Page: 2508End Page: 2518Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28639Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28639Citation Count: 104
-
OPENTitle: Multimodal Longitudinal Neurophysiological Investigations in Dopa‐Responsive DystoniaJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1986End Page: 1987Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28679Best OA location URL: https://doi.org/10.1002/mds.28679Citation Count: 6
- Caregiving concerns and clinical characteristics across neurodegenerative and cerebrovascular disorders in the Ontario neurodegenerative disease research initiative2022RESTRICTEDTitle: Caregiving concerns and clinical characteristics across neurodegenerative and cerebrovascular disorders in the Ontario neurodegenerative disease research initiativeJournal Name: International Journal of Geriatric PsychiatryPublisher: WileyVol: 37Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/gps.5727Citation Count: 8
-
OPENTitle: Description of a European memory clinic cohort undergoing amyloid‐PET: The AMYPAD Diagnostic and Patient Management StudyJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 3Start Page: 844End Page: 856Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.12696Best OA location URL: https://pub.dzne.de/search?p=id:%22DZNE-2022-01312%22Citation Count: 17
- Machine learning‐based prediction of cognitive outcomes in de novo Parkinson's disease2022RESTRICTEDTitle: Machine learning‐based prediction of cognitive outcomes in de novo Parkinson's diseaseJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 18Issue #: S5Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/alz.067067Citation Count: 6
-
OPENTitle: Comparative analytical performance of multiple plasma Aβ42 and Aβ40 assays and their ability to predict positron emission tomography amyloid positivityJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 3Start Page: 956End Page: 966Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.12697Best OA location URL: https://doi.org/10.1002/alz.12697Citation Count: 60
-
OPENTitle: Relationship of serum beta‐synuclein with blood biomarkers and brain atrophyJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 4Start Page: 1358End Page: 1371Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.12790Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.12790Citation Count: 52
-
OPENTitle: 146th Annual Meeting American Neurological AssociationJournal Name: Annals of NeurologyPublisher: WileyVol: 90Issue #: S27Start Page: S1End Page: S270Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.26180Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.26180Citation Count: 17
-
OPENTitle: Blood RNA transcripts reveal similar and differential alterations in fundamental cellular processes in Alzheimer's disease and other neurodegenerative diseasesJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 6Start Page: 2618End Page: 2632Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.12880Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11633037Citation Count: 28
- Protective Effects of Lovastatin in a Population‐BasedALSStudy and Mouse Model2023OPENTitle: Protective Effects of Lovastatin in a Population‐BasedALSStudy and Mouse ModelJournal Name: Annals of NeurologyPublisher: WileyVol: 93Issue #: 5Start Page: 881End Page: 892Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.26600Citation Count: 15
- Neural Correlates of Optimal Deep Brain Stimulation for Cervical Dystonia2022RESTRICTEDTitle: Neural Correlates of Optimal Deep Brain Stimulation for Cervical DystoniaJournal Name: Annals of NeurologyPublisher: WileyVol: 92Issue #: 3Start Page: 418End Page: 424Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.26450Citation Count: 19
- 147th Annual Meeting American Neurological Association2022RESTRICTEDTitle: 147th Annual Meeting American Neurological AssociationJournal Name: Annals of NeurologyPublisher: WileyVol: 92Issue #: S29Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.26484Citation Count: 25
- Effect of Urate-Elevating Inosine on Progression of Early Parkinson Disease2022RESTRICTEDTitle: Effect of Urate-Elevating Inosine on Progression of Early Parkinson DiseaseJournal Name: JAMAPublisher: American Medical Association (AMA)Vol: 327Issue #: 1Start Page: 85End Page: 85Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jama.2021.21008Citation Count: 5
- Effect of Urate-Elevating Inosine on Progression of Early Parkinson Disease—Reply2022RESTRICTEDTitle: Effect of Urate-Elevating Inosine on Progression of Early Parkinson Disease—ReplyJournal Name: JAMAPublisher: American Medical Association (AMA)Vol: 327Issue #: 1Start Page: 85End Page: 85Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jama.2021.21011Citation Count: 4
-
OPENTitle: Machine Learning for Predicting Rare Clinical Outcomes—Finding Needles in a HaystackJournal Name: JAMA Network OpenPublisher: American Medical Association (AMA)Vol: 4Issue #: 5Start Page: e2110738End Page: e2110738Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1001/jamanetworkopen.2021.10738Best OA location URL: https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2780278/wang_2021_ic_210094_1620949822.15523.pdfCitation Count: 22
- Reforming the Process for Deep Brain Stimulation and Neurologic Device Approval in Rare Diseases2020RESTRICTEDTitle: Reforming the Process for Deep Brain Stimulation and Neurologic Device Approval in Rare DiseasesJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 78Issue #: 1Start Page: 5End Page: 5Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2020.4232Citation Count: 3
- Ischemic Events After Intracerebral Hemorrhage2021RESTRICTEDTitle: Ischemic Events After Intracerebral HemorrhageJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 78Issue #: 7Start Page: 795End Page: 795Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2021.0772Citation Count: 3
- Bad Air and Parkinson Disease—The Fog May Be Lifting2021RESTRICTEDTitle: Bad Air and Parkinson Disease—The Fog May Be LiftingJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 78Issue #: 7Start Page: 793End Page: 793Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2021.0863Citation Count: 7
- Citius, Fortius, Altius—Understanding Which Components Drive Exercise Benefits in Parkinson Disease2021OPENTitle: Citius, Fortius, Altius—Understanding Which Components Drive Exercise Benefits in Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 78Issue #: 12Start Page: 1443End Page: 1443Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2021.3744Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2785852/jamaneurology_de_vries_2021_ed_210020_1638811688.29228.pdfCitation Count: 15
- Adjunctive Therapies in Parkinson Disease—Have We Made Meaningful Progress?2021RESTRICTEDTitle: Adjunctive Therapies in Parkinson Disease—Have We Made Meaningful Progress?Journal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 2Start Page: 119End Page: 119Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2021.4140Citation Count: 5
- Commentary on Long-term Effectiveness of Adjuvant Treatment in Parkinson Disease—Reply2022RESTRICTEDTitle: Commentary on Long-term Effectiveness of Adjuvant Treatment in Parkinson Disease—ReplyJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 7Start Page: 726End Page: 726Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.1604Citation Count: 0